- Acera Surgical Broadens Reach of Restrata ® with New FDA Clearance for Soft Tissue Reinforcement
- Riliprubart Earns Orphan Drug Designation in the US for Antibody-mediated Rejection in Solid Organ Transplantation
- The Critical Role of Cables and Sensors in Biomedical Equipment Performance
- Catalyst MedTech Secures Exclusive U.S. Distribution of CareMiBrain™ PET System with NeuroQ4™, Showcasing a complete Neurologic PET Solution at SNMMI 2025
- Allient Inc Reports: Greg Kraus Appointed Director of Strategic Operations for Allient Defense Solutions
Medical Device News Magazine
A Digital Publication Founded in 2008, and proudly located in the United States, Medical Device News Magazine has established itself as one of the foremost and most trusted sources of comprehensive updates and insights within the medical device and biotech industries. Our publication is committed to delivering timely and relevant information, making it a go-to resource for professionals and enthusiasts alike.
Medical Device News Magazine is easily accessible to readers 24/7/365, allowing you to stay informed at your convenience, and it presents content that is a fast and engaging read. We take pride in offering valuable insights in a format that can be consumed quickly, ensuring that our audience stays ahead of the curve. Furthermore, if you are interested in expanding your reach and visibility within this dynamic field, we encourage you to inquire about advertising opportunities with us.
"Medical Device and Biotechnology Sector News: Essential Key Insights and Noteworthy Developments that are Shaping the Future"
NanoHive Medical Sublicenses DirectSync’s Piezoelectric Patents to Explore Development of Hive™ Soft Titanium® 3D Printed Spine Interbody Fusion “Smart Implant”
NanoHive’s Soft Titanium® technology is the ideal interbody fusion implant to deliver a sensor with data collection and bone stimulation capability. The company is excited about the prospect of leading the way with the development of a technological leap in the interbody fusion device category.
Solventum Launches Preassembled, See-through VH2O2 Test Pack for Low-temp Medical Instrument Sterilization
The ready-to-use test integrates two previously FDA-cleared indicators – a biological indicator for confirming microbial neutralization and a chemical indicator for verifying proper sterilizer function – into a single-use test pack with a transparent container.
Eye’ on Health: AI Detects Dizziness and Balance Disorders Remotely
Discover how AI enhances remote diagnosis of dizziness and balance disorders, transforming patient care and clinical assessments.
Cochlear Introduces the Baha® 7 Sound Processor and Baha SoundBand™
Cochlear’s bone conduction hearing solutions are designed to improve hearing outcomes for children and adults with conductive hearing loss, mixed hearing loss and single-sided deafness.
Innovative Solutions for Today's Challenges, Secured Funding for a Brighter Future
Ceryx Medical Secures $15 Million | To Advance Groundbreaking Heart Failure Technology
Funding to drive development of permanent bioelectronic pacemaker following promising clinical data.
Wandercraft Announces Series D Round
Clinical progress, industrial partnerships, and global recognition drive momentum in rehabilitation, personal mobility, and humanoid robotics. The new agreement with Renault accelerates commercialization and advances Wandercraft’s global robotics footprint.
Pimicotinib Demonstrates Best-in-Class Potential with Significant Efficacy and Clinically Meaningful Improvements in Patients with Tenosynovial Giant Cell Tumor
Merck KGaA, Darmstadt, Germany, today announced the presentation of detailed positive results from Part 1 of the global Phase 3 MANEUVER trial evaluating pimicotinib in TGCT.
New Drug Approval for In-House Developed Anti-Insomnia Drug DAYVIGO (Lemborexant) in China
Eisai plans to launch this medicine in China in the second quarter of fiscal year 2025.
Comprehensive Insights into Medical Device and Biotechnology Company Mergers and Acquisitions Trends and Strategies
Boston Scientific Announces Agreement to Acquire Cortex, Inc.
Nick Spadea-Anello, global president, Electrophysiology, Boston Scientific said, “We believe the addition of the Cortex technology complements our electrophysiology portfolio with a differentiated cardiac mapping offering to assist with complex AF cases.”
Carl Marks Securities Successfully Advises Kewaunee Scientific Corporation on $55 Million Acquisition of Nu Aire
“We have maintained an advisory relationship with Kewaunee for many years and are proud to have played a role in the successful strategic acquisition of Nu Aire by Kewaunee,” added Evan Tomaskovic, Managing Partner at Carl Marks Advisors. “It is gratifying to assist a 100-year-old business complete a key acquisition of a more than 50-year-old family-owned business, fortifying the legacies of both world-class organizations.”
FDA Medical Device Updates
FDA Grants De Novo Clearance for Reflow Medical’s Spur® Peripheral Retrievable Stent System
Reflow Medical, Inc., a leading developer of innovative medical devices focused on complex cardiovascular disease, announced that the U.S. Food and Drug Administration (FDA) has
MSKai Spine Imaging Software Receives FDA 510(k) Clearance for Clinical Use
Advanced software tool supports consistent, objective evaluation of lumbar spine MRI scans.
Non-Profit Organization News and Updates
Medical Imaging Technologies and Their Impact on Modern Healthcare
Healing Headlines, Transforming Lives: Hospitals in the News
Illinois Cardiovascular Care Providers Commend Passage of Legislation Requiring Coverage for PAD Screening
Through their tireless work the bill was passed unanimously by the Illinois State Legislature on Thursday, May 29.
Knee Arthritis Made Worse with Steroid Injections
“The most striking finding is that a single corticosteroid injection led to significantly greater structural damage in the knee joint over two years, especially in cartilage, while hyaluronic acid injections not only avoided this damage but actually showed reduced joint deterioration post-injection,” she said. “Corticosteroids are known to reduce inflammation but also impair the repair mechanisms of cartilage and can inhibit matrix synthesis.”
Philips Launches RADIQAL Study to Generate Real-world Evidence for New Ultra-low X-ray Dose Technology in Coronary Procedures
This multicenter, randomized study, sponsored by Philips will enroll 824 coronary artery disease patients across 6 hospitals in Spain, Czech Republic and the US. The first patient in the study was enrolled at Aarhus University Hospital, Denmark.
Delray Medical Center Notes Vascular Surgeon Dr Joseph Ricotta 1st in the World to Utilize the Celt ACD PLUS System In a Procedure
“The Celt ACD PLUS is another surgical option for patients, ensuring that they have the best chance of a good outcome,” said Dr. Ricotta. “By investing in the latest medical technology, we remain at the forefront of innovation as medicine continues to advance.”
Dr. Ricotta is the National Medical Director of Vascular Surgery and Endovascular Therapy for Tenet Healthcare, and Professor of Surgery and Founder and Program Director of the Vascular Surgery at Florida Atlantic University’s School of Medicine.
Covenant Health Fort Sanders Regional 1st in Tennessee to Bring Perimeter Medical Imaging AI’s Pioneering Technology to Surgery
“OCT technology enhances the level of care I am able to provide and has become a valuable tool in the operating room,” said Dr. Ana Wilson, a surgical oncologist with Covenant Health Fort Sanders Regional. “It allows me to make patient-specific surgical decisions in real-time and potentially reduce the likelihood of my patients returning for a second surgery.”
Medical Device and Biotechnology Executives: Innovative Professionals on the Move and Making Waves in the Industry
AVNA INC. Appoints David Bonvenuto and Aaron Mambrino to Board of Directors
David Bonvenuto and Aaron Mambrino are appointed to its Board.
Trogenix Further Strengthens its Scientific Advisory Board with the Appointment of World-Leading Experts, Prof Nada Jabado and Prof Burkhard Becher
Appoints Professor Nada Jabado and Professor Burkhard Becher to its scientific advisory board.
Dalen Meeter Joins Aspen Neuroscience as Chief Financial Officer
With more than two decades of finance and accounting expertise, Dalen brings extensive experience in scaling private and public companies to his new role.
Dan Cummings Is Appointed Chief Commercial Officer of Precision AQ
Dan Cummings will be responsible for Precision AQ’s commercial and go-to-market strategies, with the goal of bringing Precision AQ’s comprehensive suite of capabilities to help biopharmaceutical companies advance life-changing therapies to market.
